GT Biopharma Inc.

2.27
0.02 (0.89%)
At close: Apr 17, 2025, 3:59 PM
2.33
2.42%
After-hours: Apr 17, 2025, 04:05 PM EDT

GT Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-13.16M -7.6M -20.88M -58.01M -28.3M -38.65M -259.19M -143.25M 21.03M
n/a n/a n/a n/a 317K 4K 7K 2K 1K
230K 2.2M 7.65M 33.93M 269K 5.31M 9.7M 130.12M 6.59M
n/a -137K 41K 863K 3.24M -216K -25K 1.41M 1.93M
28K -5.28M 10K 538K 18.36M 1.65M 10.18M 1.37M 1.7M
n/a n/a n/a n/a -317K 25.09M 228.51M 4.91M -34.06M
n/a 1.82M -1.99M 7.94M 2.4M 2.94M 111K 1.41M 2.81M
-12.9M -8.85M -15.22M -15.61M -7.26M -3.66M -10.68M -5.43M -1.93M
n/a n/a n/a n/a n/a n/a -36K -4K n/a
n/a n/a n/a n/a n/a 200K n/a n/a n/a
n/a n/a 12.14M -23.04M n/a n/a n/a n/a n/a
n/a n/a 12.14M n/a n/a n/a n/a n/a n/a
12.89M -2.01M -12.14M -23.04K n/a 200.00 -36K n/a -1K
12.89M -2.01M 12.14M -23.04M n/a 200K -36K -4K -1K
n/a n/a n/a 1.21M n/a 3.43M 10.73M 5.99M 1.9M
n/a n/a -224K n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a 16.43M 12.53M n/a -533K n/a n/a
2.98M 6.27M -224K 42.32M 12.53M 3.43M 10.2M 5.99M 1.9M
2.96M -4.59M -3.3M 3.67M 5.27M -32K -516K 557K -28K
-12.9M -8.85M -15.22M -15.61M -7.26M -3.66M -10.71M -5.43M -1.93M